XML 108 R95.htm IDEA: XBRL DOCUMENT v2.4.1.9
Related Party Transactions - Additional Information (Detail) (USD $)
In Thousands, except Share data, unless otherwise specified
12 Months Ended 33 Months Ended 0 Months Ended
Dec. 31, 2014
Dec. 31, 2013
Dec. 31, 2012
Oct. 31, 2013
Dec. 17, 2013
Sep. 30, 2013
Nov. 20, 2013
Oct. 01, 2013
Dec. 07, 2014
Sep. 30, 2014
Related Party Transaction [Line Items]                    
Contribution of services by shareholder $ 1,991xon_ContributionOfServicesByShareholder $ 1,550xon_ContributionOfServicesByShareholder $ 1,550xon_ContributionOfServicesByShareholder              
Collaboration revenue 45,212xon_CollaborationRevenues 23,525xon_CollaborationRevenues 13,706xon_CollaborationRevenues              
Upfront and milestone payments                    
Related Party Transaction [Line Items]                    
Collaboration revenue 9,625xon_CollaborationRevenues
/ us-gaap_ProductOrServiceAxis
= xon_UpfrontAndMilestonePaymentsMember
6,944xon_CollaborationRevenues
/ us-gaap_ProductOrServiceAxis
= xon_UpfrontAndMilestonePaymentsMember
5,851xon_CollaborationRevenues
/ us-gaap_ProductOrServiceAxis
= xon_UpfrontAndMilestonePaymentsMember
             
Third Security, LLC                    
Related Party Transaction [Line Items]                    
Total amount of expenses reimbursed 291us-gaap_ProfessionalAndContractServicesExpense
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_ThirdSecurityMember
455us-gaap_ProfessionalAndContractServicesExpense
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_ThirdSecurityMember
49us-gaap_ProfessionalAndContractServicesExpense
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_ThirdSecurityMember
             
Chief Executive Officer                    
Related Party Transaction [Line Items]                    
Contribution of services by shareholder 1,991xon_ContributionOfServicesByShareholder
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_ChiefExecutiveOfficerMember
1,550xon_ContributionOfServicesByShareholder
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_ChiefExecutiveOfficerMember
1,550xon_ContributionOfServicesByShareholder
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= us-gaap_ChiefExecutiveOfficerMember
             
ZIOPHARM Oncology, Inc.                    
Related Party Transaction [Line Items]                    
Purchase of additional common stock 50,000xon_AdditionalSharesValueAgreedToPurchase
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_ZiopharmMember
                 
Shares of common stock purchased from collaborative partners, value       30,982xon_SharesPurchasedFromCollaborativePartnersValue
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_ZiopharmMember
           
Purchase commitment 19,081xon_SharesPurchaseCommitmentRemainingValue
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_ZiopharmMember
                 
Synthetic Biologics, Inc.                    
Related Party Transaction [Line Items]                    
Maximum percentage of shares of future securities offerings of collaborative partners to which the entity is entitled to purchase 19.99%xon_MaximumPercentageOfSharesEntitledToPurchase
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_SyntheticBiologicsMember
                 
Shares of common stock purchased from collaborative partners         2,000,000xon_SharesPurchasedFromCollaborativePartners
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_SyntheticBiologicsMember
         
Price per share of common shares         $ 1.00xon_SharesPurchasedPricePerShare
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_SyntheticBiologicsMember
         
Additional shares of collaborative partner to which the entity is entitled to purchase on the open market 10.00%xon_MaximumAdditionalPercentageOfSharesEntitledToPurchaseInOpenMarket
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_SyntheticBiologicsMember
                 
Oragenics, Inc.                    
Related Party Transaction [Line Items]                    
Maximum percentage of shares of future securities offerings of collaborative partners to which the entity is entitled to purchase 30.00%xon_MaximumPercentageOfSharesEntitledToPurchase
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_OragenicsMember
                 
Shares of common stock purchased from collaborative partners           1,300,000xon_SharesPurchasedFromCollaborativePartners
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_OragenicsMember
       
Price per share of common shares           $ 3.00xon_SharesPurchasedPricePerShare
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_OragenicsMember
       
Oragenics, Inc. | Share Purchase Rights Plan                    
Related Party Transaction [Line Items]                    
Shares of common stock purchased from collaborative partners             1,100,000xon_SharesPurchasedFromCollaborativePartners
/ invest_InvestmentAxis
= xon_SharePurchaseRightsPlanMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_OragenicsMember
     
Price per share of common shares             $ 2.50xon_SharesPurchasedPricePerShare
/ invest_InvestmentAxis
= xon_SharePurchaseRightsPlanMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_OragenicsMember
     
Fibrocell Science, Inc.                    
Related Party Transaction [Line Items]                    
Shares of common stock purchased from collaborative partners               2,439,024xon_SharesPurchasedFromCollaborativePartners
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_FibrocellMember
   
Price per share of common shares               $ 4.10xon_SharesPurchasedPricePerShare
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_FibrocellMember
   
Histogenics Corporation                    
Related Party Transaction [Line Items]                    
Shares of common stock purchased from collaborative partners                 1,772,364xon_SharesPurchasedFromCollaborativePartners
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_HistogenicsCorporationMember
 
Price per share of common shares                 $ 11.00xon_SharesPurchasedPricePerShare
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_HistogenicsCorporationMember
 
Note receivable interest rate                   6.00%xon_NoteReceivableInterestRate
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_HistogenicsCorporationMember
Histogenics Corporation | Upfront and milestone payments | Upfront                    
Related Party Transaction [Line Items]                    
Collaborative arrangement consideration received, value of convertible promissory note                   10,000xon_CollaborativeArrangementConsiderationReceivedValueOfConvertiblePromissoryNote
/ us-gaap_ContingentConsiderationByTypeAxis
= xon_UpfrontMember
/ us-gaap_ProductOrServiceAxis
= xon_UpfrontAndMilestonePaymentsMember
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_HistogenicsCorporationMember
Related Parties, Aggregated                    
Related Party Transaction [Line Items]                    
Collaboration revenue $ 41,030xon_CollaborationRevenues
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_RelatedPartiesAggregatedMember
$ 22,783xon_CollaborationRevenues
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_RelatedPartiesAggregatedMember
$ 13,076xon_CollaborationRevenues
/ us-gaap_RelatedPartyTransactionsByRelatedPartyAxis
= xon_RelatedPartiesAggregatedMember